A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
-
Narrated by:
-
By:
About this listen
Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Show reference:
https://www.nejm.org/doi/10.1056/NEJMoa2413449
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.